Date lodged: 29 September 2016
To ask the Scottish Government what its position is on increasing the faecal protection testing that is required to differentiate between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
Answered by: Shona Robison 27 October 2016
We welcome the publication of ‘Scotland Leading the Way: a National Blueprint for IBD in Scotland’, published in 2016 by Crohn’s and Colitis UK with support from the Scottish Government, which recommends the use of faecal calprotectin testing (FCP) as an option to support clinicians in ensuring timely referral for IBD diagnosis. This recommendation is supported by current clinical evidence of the value of FCP in preventing the need for more invasive investigations for people with a diagnosis of IBS. We will continue to work with C&CUK to engage with NHS boards and encourage improvements as set out in the Blueprint.